Photo Gallery



News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  • WJPPS Impact Factor
  • Its our Pleasure to Inform you that WJPPS Impact Factor has been increased from  7.454 to 7.632  due to high quality Publication at International Level

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • FEBRUARY 2021 Issue has been successfully launched on 1 February 2021.



Happy Patil*


Epilepsy affects 50 million people worldwide, with a prevalence of 4-10 per 1000 in the UK. Ten percent of people will have a seizure during their lifetime, without necessarily developing epilepsy. The risk of an individual developing epilepsy in their in their lifetime is 3-5%. Essentially, regardless of your chosen specialty, it is likely you will encounter patients with epilepsy, either during an acute seizure event or as a co-morbid condition. Like any chronic medical condition, the aim of management is to allow patients to live life as normally as possible: indeed, this is the case for the majority of patients, with up to 70% becoming seizure-free on monotherapy.

Keywords: Seizures, Epilepticus, GABA, Brain.

[Full Text Article]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More